{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Durham&page=53&state=North+Carolina", "query": { "state": "North Carolina", "city": "Durham", "page": 53 }, "page_size": 10 }, "pagination": { "page": 53, "page_size": 10, "total_count": 1197, "total_pages": 120, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Durham&page=54&state=North+Carolina&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Durham&page=52&state=North+Carolina&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T08:21:14.118Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04593940", "title": "Immune Modulators for Treating COVID-19", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "Infliximab", "type": "DRUG" }, { "name": "Abatacept", "type": "DRUG" }, { "name": "Remdesivir", "type": "DRUG" }, { "name": "cenicriviroc (closed to enrollment as of 3-Sep-2021)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daniel Benjamin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1971, "start_date": "2020-10-15", "completion_date": "2022-03-05", "has_results": true, "last_update_posted_date": "2023-09-25", "last_synced_at": "2026-11-15T08:21:14.118Z", "location_count": 67, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • La Jolla, California + 54 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Moreno Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04593940" }, { "nct_id": "NCT00003724", "title": "Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Metastatic Cancer" ], "interventions": [ { "name": "surgical procedure", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 530, "start_date": "1999-02", "completion_date": "2007-02", "has_results": false, "last_update_posted_date": "2016-07-12", "last_synced_at": "2026-11-15T08:21:14.118Z", "location_count": 45, "location_summary": "La Jolla, California • San Francisco, California • Wilmington, Delaware + 27 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Wilmington", "state": "Delaware" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003724" }, { "nct_id": "NCT00101127", "title": "Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sarcoma" ], "interventions": [ { "name": "filgrastim", "type": "BIOLOGICAL" }, { "name": "pegfilgrastim", "type": "BIOLOGICAL" }, { "name": "docetaxel", "type": "DRUG" }, { "name": "gemcitabine hydrochloride", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Gynecologic Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": null, "start_date": "2003-12", "completion_date": null, "has_results": false, "last_update_posted_date": "2014-02-14", "last_synced_at": "2026-11-15T08:21:14.118Z", "location_count": 60, "location_summary": "Los Angeles, California • Hartford, Connecticut • New Britain, Connecticut + 47 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "New Britain", "state": "Connecticut" }, { "city": "Newark", "state": "Delaware" } ], "official_url": "https://clinicaltrials.gov/study/NCT00101127" }, { "nct_id": "NCT05604170", "title": "Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tuberous Sclerosis Complex" ], "interventions": [ { "name": "Ganaxolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Marinus Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "65 Years", "sex": "ALL", "summary": "1 Year to 65 Years" }, "enrollment_count": 117, "start_date": "2022-05-16", "completion_date": "2025-04-02", "has_results": true, "last_update_posted_date": "2025-10-01", "last_synced_at": "2026-11-15T08:21:14.118Z", "location_count": 20, "location_summary": "Little Rock, Arkansas • Los Angeles, California • Orange, California + 17 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05604170" }, { "nct_id": "NCT00687102", "title": "Cognition in the Study of Tamoxifen and Raloxifene", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cognition", "Aging" ], "interventions": [ { "name": "tamoxifen", "type": "DRUG" }, { "name": "raloxifene", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wake Forest University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "FEMALE", "summary": "65 Years and older · Female only" }, "enrollment_count": 1498, "start_date": "2001-10", "completion_date": "2008-03", "has_results": true, "last_update_posted_date": "2018-09-12", "last_synced_at": "2026-11-15T08:21:14.118Z", "location_count": 127, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Camp Pendleton, California + 102 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Camp Pendleton", "state": "California" }, { "city": "Duarte", "state": "California" }, { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00687102" }, { "nct_id": "NCT01864200", "title": "Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Snake Bites" ], "interventions": [ { "name": "Crotalidae polyvalent immune fab (ovine)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "BTG International Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 74, "start_date": "2013-07", "completion_date": "2015-12", "has_results": true, "last_update_posted_date": "2017-11-22", "last_synced_at": "2026-11-15T08:21:14.118Z", "location_count": 18, "location_summary": "Augusta, Georgia • Kansas City, Kansas • St Louis, Missouri + 14 more", "locations": [ { "city": "Augusta", "state": "Georgia" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01864200" }, { "nct_id": "NCT02415400", "title": "A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Acute Coronary Syndromes" ], "interventions": [ { "name": "Apixaban", "type": "DRUG" }, { "name": "vitamin K antagonist", "type": "DRUG" }, { "name": "Acetylsalicylic acid", "type": "DRUG" }, { "name": "Acetylsalicylic acid placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "18 Years to 95 Years" }, "enrollment_count": 4614, "start_date": "2015-06-04", "completion_date": "2018-11-10", "has_results": true, "last_update_posted_date": "2020-06-11", "last_synced_at": "2026-11-15T08:21:14.118Z", "location_count": 143, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 125 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02415400" }, { "nct_id": "NCT00117962", "title": "Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lung Cancer" ], "interventions": [ { "name": "cetuximab", "type": "BIOLOGICAL" }, { "name": "carboplatin", "type": "DRUG" }, { "name": "pemetrexed disodium", "type": "DRUG" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "RADIATION" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 109, "start_date": "2005-09", "completion_date": "2012-09", "has_results": true, "last_update_posted_date": "2016-10-07", "last_synced_at": "2026-11-15T08:21:14.118Z", "location_count": 71, "location_summary": "Arroyo Grande, California • Castro Valley, California • Hayward, California + 56 more", "locations": [ { "city": "Arroyo Grande", "state": "California" }, { "city": "Castro Valley", "state": "California" }, { "city": "Hayward", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00117962" }, { "nct_id": "NCT01579370", "title": "Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Multidrug Resistant Organisms", "Healthcare Associated Infections" ], "interventions": [ { "name": "Quaternary ammonium", "type": "OTHER" }, { "name": "Bleach", "type": "OTHER" }, { "name": "Quaternary ammonium and UV-C light", "type": "OTHER" }, { "name": "Bleach and UV-C light", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 21395, "start_date": "2012-04", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2015-11-17", "last_synced_at": "2026-11-15T08:21:14.118Z", "location_count": 9, "location_summary": "Burlington, North Carolina • Chapel Hill, North Carolina • Durham, North Carolina + 3 more", "locations": [ { "city": "Burlington", "state": "North Carolina" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01579370" }, { "nct_id": "NCT00948636", "title": "Stem Cell Related Donor Safety Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Related Hematopoietic Stem Cell Donors" ], "interventions": [], "intervention_types": [], "sponsor": "Center for International Blood and Marrow Transplant Research", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1812, "start_date": "2010-01", "completion_date": "2016-09", "has_results": false, "last_update_posted_date": "2017-06-14", "last_synced_at": "2026-11-15T08:21:14.118Z", "location_count": 52, "location_summary": "Phoenix, Arizona • San Diego, California • San Francisco, California + 44 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00948636" } ] }